The University of Southampton
University of Southampton Institutional Repository

Molecular pathways in the development and treatment of oesophageal cancer

Molecular pathways in the development and treatment of oesophageal cancer
Molecular pathways in the development and treatment of oesophageal cancer
The molecular pathways involved in the development and treatment of oesophageal cancer are complex. Recent large-scale genome sequencing studies have delivered novel insights into aetiology and possible targeted treatments. Oesophageal squamous cell carcinoma (OSCC) and adenocarcinoma (OAC) are distinct entities. At the molecular level OSCC is more similar to squamous cell cancers in other organs than OAC. Whilst considerable heterogeneity exists in both tumour types new data suggests that driver gene events and mutational signatures may be able to categorise tumours into potentially actionable subtypes. Taken together these findings not only suggest new avenues for treatments in a cancer type with appalling outcomes, but also a new era of molecular rather than purely anatomical classification and staging of oesophageal cancer.
1521-6918
9-15
Walker, Robert Charles
5a7a4629-6996-4975-8ed1-a18614db491b
Underwood, Timothy
8e81bf60-edd2-4b0e-8324-3068c95ea1c6
Walker, Robert Charles
5a7a4629-6996-4975-8ed1-a18614db491b
Underwood, Timothy
8e81bf60-edd2-4b0e-8324-3068c95ea1c6

Walker, Robert Charles and Underwood, Timothy (2018) Molecular pathways in the development and treatment of oesophageal cancer. Best Practice & Research: Clinical Gastroenterology, 36-37, 9-15. (doi:10.1016/j.bpg.2018.11.013).

Record type: Article

Abstract

The molecular pathways involved in the development and treatment of oesophageal cancer are complex. Recent large-scale genome sequencing studies have delivered novel insights into aetiology and possible targeted treatments. Oesophageal squamous cell carcinoma (OSCC) and adenocarcinoma (OAC) are distinct entities. At the molecular level OSCC is more similar to squamous cell cancers in other organs than OAC. Whilst considerable heterogeneity exists in both tumour types new data suggests that driver gene events and mutational signatures may be able to categorise tumours into potentially actionable subtypes. Taken together these findings not only suggest new avenues for treatments in a cancer type with appalling outcomes, but also a new era of molecular rather than purely anatomical classification and staging of oesophageal cancer.

Text
Molecular Pathways Chapter Final_PP_RA - Accepted Manuscript
Download (156kB)

More information

Accepted/In Press date: 20 November 2018
e-pub ahead of print date: 23 November 2018

Identifiers

Local EPrints ID: 426517
URI: http://eprints.soton.ac.uk/id/eprint/426517
ISSN: 1521-6918
PURE UUID: e5a7e8af-52c1-4cf9-8ef3-c4c71ecab412
ORCID for Timothy Underwood: ORCID iD orcid.org/0000-0001-9455-2188

Catalogue record

Date deposited: 29 Nov 2018 17:30
Last modified: 16 Mar 2024 07:21

Export record

Altmetrics

Contributors

Author: Robert Charles Walker

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×